Dr Shishir Shetty is a Cancer Research UK Advanced Clinician Scientist and principal investigator in the Centre for Liver and Gastrointestinal Research.
University of Birmingham experts are leading discussions at the 2021 International Liver Congress citing the effects of COVID-19 on people with liver disease.
An open letter to the G7 from the BactiVac Network emphasising the need for a global effort to combat the threat posed by anti-microbial resistant bacteria.
A University of Birmingham-led study of dental professionals has shown their increased risk of SARS-CoV-2 infection during the first wave of the pandemic.
A University of Birmingham-led study has found that many patients with COVID-19 produce immune responses against their body's own tissues or organs.
New study finds antibody responses in people over 80 is three-and-a-half times greater in those who have the second dose of the Pfizer vaccine after 12 weeks.
A new study aims to explore the immune response to natural COVID-19 infection and vaccination in patients with antibody deficiency.
Latest research has found a new approach to tackling viruses by targeting the 'control centre' in viral RNA, leading to broad spectrum anti-viral drugs.
The University of Birmingham is part of a new industry collaboration to accelerate drug discovery projects that will fast track research from lab to patient.
Over 200 scientists and industry figures worldwide gathered online for the BactiVac Virtual Network Conference 2021 hosted at the University of Birmingham.
Work is set to begin on the first phase of Birmingham Health Innovation Campus this Summer after planning permission was granted by Birmingham City Council.
Latest study finds over-80's receiving a dose of either the Pfizer or AstraZeneca COVID vaccine show equivalent antibody responses five weeks post vaccination.